Oral administration of G. lucidum extracts suppressed lung cancer tumor growth in mice and suppressed the activation of PKB (Akt), mechanistic target of rapamycin (mTOR), S6 kinase, and 4E-BP1 in lung cancer cells [52]. Here, EIF4EBP1 is linked to lung carcinoma.